分子診断薬（MDx）市場レポート：2022-2032

Molecular Diagnostics (MDx) Market Report 2022-2032

レポート詳細分子診断薬（MDx）市場レポート 2022-2032 :本レポートは、新たな収益の柱を目指すリーディングカンパニーが、業界とその背景にあるダイナミクスをより深く理解する上で、非常に有益な... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
Visiongain ヴィジョンゲイン社	2022年9月1日	GBP4,500 部署ライセンスライセンス・価格情報注文方法はこちら	236	279	英語

※上記価格は部署ライセンス（Departmental licence）価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

レポート詳細

分子診断薬（MDx）市場レポート 2022-2032:本レポートは、新たな収益の柱を目指すリーディングカンパニーが、業界とその背景にあるダイナミクスをより深く理解する上で、非常に有益なものとなるでしょう。また、異業種への進出や新地域での既存事業の拡大を目指す企業にとっても有用なレポートです。

ポイントオブケア診断のニーズの高まりが市場成長の主な要因の1つ
携帯型分子診断薬には、咽頭拭い液、血液、血清、便などのヒト試料から病気を検出・診断するためのアッセイやキットが含まれます。分子診断薬は、集中型ラボからポイントオブケア型分子検査へと移行しつつあります。

ポイントオブケア検査は、POC検査とも呼ばれ、医療の現場またはその近くで行われる医療検査の一種です。POCは患者さんのいる現場を示しています。すべてのサンプルや検体を医療機関に送って処理することは、結果が出るまで長い時間待つことを意味します。POC検査は、特に、タイムリーな医療へのアクセスに多くの課題を抱え、医療インフラがまだ古い発展途上国において、感染症管理を大きく改善することができます。

さまざまな疾患の有病率の上昇は、ポイントオブケア検査法の開発を加速させ、分子診断市場の成長を後押ししています。UNAIDS Data of 2020によると、2018年に東・南アフリカの約2060万人がHIVとともに生活しています。2019年の中東・北アフリカでは、2万人の新規HIV感染者が報告されました。

2019年、アジア太平洋地域では推定580万人がHIVに感染しており、インドと中国がその先頭を走っています。UNAIDSによると、2019年にインドで約210万人がHIV陽性となりました。HIVの高い感染率は、ポイントオブケア診断薬の需要を高め、HIV感染症の治療を早めることが期待されます。

世界的なワクチン接種数の増加と分子検査薬の価格上昇
COVID-19の大流行により、診断薬業界では、新規かつ迅速なコロナウイルス検出キットの開発競争に火がつきました。感染症分野の企業は、パンデミックの結果、収益が増加しました。例えば、サーモフィッシャーサイエンティフィックは2021年4月に59%の増収を記録しましたが、これは診断薬部門の150%増によるものです。しかし、世界的なワクチン接種率の上昇に伴い、COVID-19診断薬の需要は予測期間中に減少すると予想されます。

分子生物学的診断法は、正確で効果的な結果をもたらし、疾病診断において重要な用途を有しています。しかし、この市場の主な阻害要因の1つは、分子検査にかかるコストが高いことです。

マーケットリサーチレポートを購入する前に、どのような質問をすべきでしょうか？
- 分子診断薬市場はどのように進化しているのか？
- 分子診断薬市場の推進要因と抑制要因は何か？
- 各分子診断サブマーケットセグメントは予測期間中にどのように成長し、2032年にはどの程度の売上を占めるようになるのか？
- 2022年から2032年にかけて、各分子診断サブマーケットの市場シェアはどのように推移するのか？
- 2022年から2032年にかけて、市場全体の主なドライバーは何になるのだろうか？
- 分子診断薬の主要市場はマクロ経済のダイナミクスに概ね追随するのか、それとも個々の国内市場が他を凌駕するのか？
- 2032年までに各国市場のシェアはどのように変化し、どの地域が2032年に市場をリードするのか？
- 主要プレイヤーは誰か、また予測期間中の展望は？
- これらのリーディング企業の分子診断プロジェクトはどのようなものか？
- 2020年から2032年の間に、業界はどのように進化していくのか？現在および今後10年間に実施される分子診断薬プロジェクトはどのような意味を持つのか？
- 分子診断薬市場の規模をさらに拡大するために、製品の商業化の必要性は高いか？
- 分子診断市場はどこへ向かい、どのようにすれば市場の最前線に立つことができるのか？
- 新製品やサービスラインに対する最適な投資オプションは何か？
- 企業を新たな成長軌道に乗せ、C-suiteに移行させるための重要な展望とは？

このことが、現在、そして今後10年間の分子診断薬市場にどのような影響を与えるかを知る必要があります。
- 本レポートは236ページにわたり、106の表と173のグラフを掲載しています。
- このレポートでは、業界における主要な収益性の高い分野をハイライトしているため、今すぐターゲットを絞ることができます。
- 世界、地域、国別の売上高と成長率を詳細に分析しています。
- 競合他社が成功した主要なトレンド、変化、収益予測をハイライトしています。

本レポートは、分子診断薬市場が今後10年間にどのように発展するか、またCOVID-19の景気後退と回復の変動に伴ってどのように変化するかを教えてくれます。この市場は、過去10年間のどの時点よりも、今がより重要なのです。

レポートでは、COVID-19のバリエーションや経済データなど、お客様の市場に特化した独自の情報をお届けしています。

2032年までの予測やその他の分析から、商業的な展望が見えてくる
- 2032年までの収益予測に加え、直近の実績、成長率、市場シェアなどをご紹介します。
- ビジネスの展望や展開など、独自の分析もご覧いただけます。
- 定性的分析（市場ダイナミクス、ドライバー、機会、阻害要因、課題など）、コスト構造、分子診断薬価格高騰の影響、最近の動向をご覧いただけます。

本レポートには、COVID-19が業界や貴社にどのような影響を与えるかについてのデータ分析および貴重な洞察が含まれています。COVID-19の4つの回収パターンとその影響、すなわち「V」、「L」、「W」、「U」については、本レポートで考察しています。

報告書でカバーするセグメント

タイプ別
- 検査サービスプロバイダー
- 診断メーカー
- OEM
- ソフトウェアプロバイダー

用途別
- 感染症診断薬
- COVID-19
- 肝炎
- HIV
- CT/NG
- HAI
- HPV
- 結核
- インフルエンザ
- その他
- オンコロジー検査
- 遺伝子検査
- その他

エンドユーザー別
- 診断研究所
- 病院・クリニック
- その他のエンドユーザー

世界市場全体およびセグメントの収益予測に加え、4地域および20の主要国市場の収益予測も掲載しています。

北米
- 米国
- カナダ
- メキシコ

欧州
- ドイツ
- スペイン
- イギリス
- フランス
- イタリア
- その他の欧州

アジア太平洋
- 中国
- 日本
- インド
- オーストラリア
- 韓国
- その他のアジア太平洋地域

LAMEA
- ブラジル
- トルコ
- サウジアラビア
- 南アフリカ
- UAE
-その他の中南米地域

分子診断薬市場の2022年から2032年までの主要企業のプロファイルと、これらの企業の事業のこのセグメントに焦点を当てたものも含まれています。

主要企業と市場成長の可能性
・ Abbott Laboratories Inc
・ F. Hoffmann-La Roche Ltd.
・ Hologic Inc.
・ Qiagen N.V.
・ Becton, Dickinson and Company
・ Cepheid
・ Siemens Medical Solutions Inc.
・ Danaher Corp.
・ Agilent Technologies Inc.
・ Exact Sciences Corp
・ Abacus Diagnostica Oy [Uniogen] ・ PerkinElmer, Inc.
・ bioMérieux SA
・ Thermo Fisher Scientific

分子診断薬市場の世界全体の収益、2022年から2032年まで、金額ベースで2022年に234億9820万米ドルを超えると、我々の仕事は計算しています。2032年まで力強い収益成長が予測されます。本調査では、最も大きな可能性を秘めた企業を特定しています。彼らの能力、進歩、商業的展望を知ることで、一歩先を行くことができます。

分子診断薬市場、2022年から2032年までのレポートはどのように役立つのでしょうか？
230ページを超えるレポートでは、要約すると以下のような知識を得ることができます。

- 分子診断市場の2032年までの収益予測、プロセス、上流、下流、タイプ、企業規模の各予測を世界と地域レベルで掲載 - 業界の展望を見出し、投資と収益に最も有利な場所を見つけることができます。

- 4つの地域と20の主要国市場の2032年までの収益予測 - 分子診断市場、2022年から2032年までの北米、ヨーロッパ、アジア太平洋、LAMEAの市場予測をご覧ください。また、米国、カナダ、メキシコ、ブラジル、ドイツ、フランス、イギリス、イタリア、中国、インド、日本、オーストラリアなどの主要経済圏の市場も予測されています。

- 既存企業および市場参入を目指す企業の展望 - 分子診断市場に関わる主要企業20社の企業プロファイルを含む、2022年から2032年までの展望。

定量的・定性的な分析と独自の予測をご覧いただけます。私たちのレポートだけが持つ情報を入手し、貴重なビジネスインテリジェンスを得ることができます。

他にはない情報
私たちの新しいレポートがあれば、知識の遅れを取り戻し、チャンスを逃す可能性が低くなります。私たちの研究が貴社の調査、分析、意思決定にどのように役立つかをご覧ください。Visiongainの研究は、分子診断市場、2022年から2032年、市場をリードする企業のための商業分析を必要とするすべての人のためのものです。データ、トレンド、予測をご覧いただけます。

ページTOPに戻る

1.レポートの概要
1.1 研究の目的
1.2 分子診断薬市場の紹介
1.3 本レポートが提供するもの
1.4 本レポートを読むべき理由
1.5 分析レポートが回答する主な質問には以下が含まれます。
1.6 本レポートは誰のためのものなのか？
1.7 方法論
1.7.1 市場の定義
1.7.2 市場評価・予測手法
1.7.3 データの検証
1.8 よくある質問と回答（FAQ）
1.9 関連するVisiongainレポート
1.10 Visiongainについて

2 エグゼクティブサマリー

3 プレミアムインサイト
3.1 タイプ別スナップショット。分子診断薬の世界市場
3.2 アプリケーションセグメント市場魅力度指数
3.3 エンドユーザーセグメント市場魅力度指標
3.4 地域別セグメント市場魅力度指標

4 市場概要
4.1 主要な調査結果
4.2 マーケットダイナミクス
4.2.1 市場の推進要因
4.2.2 市場の抑制要因
4.2.3 市場機会
4.3 ポーターのファイブフォース分析
4.3.1 サプライヤー・パワー
4.3.2 バイヤーパワー
4.3.3 競合他社の競争力
4.3.4 代替品による脅威
4.3.5 新規参入者の脅威
4.4 PESTEL分析

5 世界の分子診断薬市場分析：タイプ別
5.1 主な調査結果
5.2 タイプ別成長展望
5.3 分子診断薬の世界市場タイプ別シェア（2022年＆2032年）
5.4 検査サービスプロバイダー
5.4.1 検査サービスプロバイダー地域別市場予測、2022年～2032年 (US$ Mn)
5.4.2 検査サービスプロバイダー地域別市場シェア、2022年～2032年（%）
5.5 診断キットメーカー
5.5.1 診断キットメーカーの地域別市場予測（2022年～2032年）（US$ Mn）
5.5.2 診断キットメーカーの地域別市場シェア、2022年～2032年(%)
5.6 OEM
5.6.1 OEMの地域別市場予測、2022-2032年 (US$ Mn)
5.6.2 OEMの地域別市場シェア、2022-2032年(%)
5.7 ソフトウェアプロバイダ
5.7.1 ソフトウェアプロバイダの地域別市場予測（2022年〜2032年）（US$ Mn）
5.7.2 ソフトウェアプロバイダの地域別市場シェア、2022-2032 (%)

6 世界の分子診断薬市場分析：用途別
6.1 主な調査結果
6.2 アプリケーション別の成長展望
6.3 分子診断薬世界市場アプリケーション別シェア（2022年＆2032年）
6.4 感染症検査
6.4.1 感染症検査の地域別市場予測、2022年～2032年 (US$ Mn)
6.4.2 感染症検査の地域別市場シェア、2022年～2032年(%)
6.4.3 HIVの地域別市場シェア、2022年〜2032年(%)
6.4.4 CT/NGの地域別市場シェア, 2022-2032年(%)
6.4.5 HAI市場地域別シェア, 2022-2032年(%)
6.4.6 インフルエンザ地域別市場シェア, 2022-2032年(%)
6.5 オンコロジーテスティング
6.5.1 オンコロジーテストの地域別市場予測、2022-2032 (US$ Mn)
6.5.2 オンコロジーテストの地域別市場シェア、2022-2032年(%)
6.6 遺伝子検査
6.6.1 遺伝子検査の地域別市場予測, 2022-2032 (US$ Mn)
6.6.2 遺伝学的検査の地域別市場シェア、2022-2032 (%)
6.7 その他
6.7.1 その他の地域別市場予測, 2022-2032 (US$ Mn)
6.7.2 その他地域別市場シェア、2022-2032年(%)

7 世界の分子診断薬市場分析：エンドユーザー別
7.1.1 主な調査結果
7.1.2 エンドユーザーセグメントの成長展望
7.2 分子診断薬の世界市場規模予測・エンドユーザー別予測
7.3 診断ラボラトリー
7.3.1 診断ラボラトリーの地域別市場予測、2022-2032年 (US$ Mn)
7.3.2 診断ラボラトリー地域別市場シェア、2022年～2032年(%)
7.4 ホスピタル＆クリニック
7.4.1 ホスピタル＆クリニックの地域別市場予測, 2022-2032 (US$ Mn)
7.4.2 ホスピタル＆クリニックの地域別市場シェア（2022-2032年）(%)

8 世界の分子診断薬市場分析：地域別
8.1 主な調査結果
8.2 地域別市場規模の推定と予測
8.3 COVID-19のインパクト分析

9 北米の分子診断薬市場分析
9.1 主な調査結果
9.2 北米分子診断薬市場の魅力度指数
9.3 北米分子診断薬国別市場、2022年、2027年＆2032年（US$ Mn)
9.4 北米分子診断薬国別市場規模推定・予測
9.5 北米分子診断薬市場タイプ別市場規模予測・予測
9.6 北米分子診断薬市場の用途別市場規模予測・予想
9.7 北米分子診断薬市場のエンドユーザー別市場規模予測・予想
9.8 米国
9.9 カナダ

10 欧州の分子診断薬市場分析
10.1 主な調査結果
10.2 欧州分子診断薬市場魅力度指数
10.3 欧州分子診断薬国別市場、2022年、2027年＆2032年（US$ Mn)
10.4 欧州分子診断薬の国別市場規模予測・予測
10.5 欧州分子診断薬市場タイプ別市場規模予測・予測
10.6 欧州の分子診断薬の市場規模予測・用途別予測
10.7 欧州分子診断薬市場のエンドユーザー別市場規模予測・予想
10.8 ドイツ
10.9 フランス
10.10 イギリス
10.11 イタリア
10.12 スペイン
10.13 ロシア

11 アジア太平洋地域の分子診断薬市場分析
11.1 主な調査結果
11.2 アジア太平洋地域の分子診断薬市場の魅力度指数
11.3 アジア太平洋地域の分子診断薬国別市場、2022年、2027年＆2032年（US$ Mn)
11.4 アジア太平洋地域の分子診断薬の国別市場規模の推定と予測
11.5 アジア太平洋地域の分子診断薬市場規模予測・予測：タイプ別
11.6 アジア太平洋地域の分子診断薬の市場規模予測・用途別予測
11.7 アジア太平洋地域の分子診断薬の市場規模予測・予想：エンドユーザー別
11.8 日本
11.9 中国
11.10 インド
11.11 オーストラリア
11.12 韓国
11.13 その他のアジア太平洋地域

12 ラテンアメリカの分子診断薬市場の分析
12.1 主な調査結果
12.2 ラテンアメリカの分子診断薬市場の魅力度指数
12.3 ラテンアメリカの分子診断薬国別市場、2022年、2027年＆2032年（百万米ドル）
12.4 ラテンアメリカの分子診断薬市場規模予測・国別予測
12.5 ラテンアメリカの分子診断薬市場規模予測・種類別予測
12.6 ラテンアメリカの分子診断薬の市場規模推定と用途別予測
12.7 ラテンアメリカの分子診断薬の市場規模予測・予想：エンドユーザー別
12.8 ブラジル
12.9 メキシコ

13 中東・アフリカの分子診断薬市場分析
13.1 主な調査結果
13.2 中東・アフリカ分子診断薬市場魅力度指数
13.3 中東・アフリカ分子診断薬国別市場、2022年、2027年、2032年 (US$ Mn)
13.4 中東・アフリカ分子診断薬国別市場規模推定・予測
13.5 中東・アフリカ分子診断薬市場タイプ別市場規模予測・予測
13.6 中東・アフリカ分子診断薬市場の用途別市場規模予測・予想
13.7 中東・アフリカ分子診断薬市場のエンドユーザー別市場規模予測・予想
13.8 GCC
13.9 南アフリカ

14 競合他社の状況
14.1 企業シェア分析
14.2 主要事業戦略分析

15 主要企業のプロフィール
15.1 アボット・ラボラトリーズ・インク
15.1.1 企業スナップショット
15.1.2 会社概要
15.1.3 財務分析
15.1.4 製品ベンチマーク
15.1.5 戦略的展望
15.2 F. ホフマン・ラ・ロシュ社
15.2.1 企業スナップショット
15.2.2 会社概要
15.2.3 財務分析
15.2.4 製品ベンチマーク
15.2.5 戦略的な展望
15.3 ホロジック社
15.3.1 企業スナップショット
15.3.2 会社概要
15.3.3 財務分析
15.3.4 製品ベンチマーク
15.3.5 戦略的な展望
15.4 キアゲンN.V.
15.4.1 企業スナップショット
15.4.2 会社概要
15.4.3 財務分析
15.4.4 製品ベンチマーク
15.4.5 戦略的な展望
15.5 ベクトンディッキンソンアンドカンパニー
15.5.1 企業スナップショット
15.5.2 会社概要
15.5.3 財務分析
15.5.4 製品ベンチマーク
15.5.5 戦略的な展望
15.6 セファイド
15.6.1 企業スナップショット
15.6.2 会社概要
15.6.3 製品ベンチマーク
15.6.4 戦略的展望
15.7 シーメンス・メディカル・ソリューションズ
15.7.1 企業スナップショット
15.7.2 会社概要
15.7.3 財務分析
15.7.4 製品ベンチマーク
15.7.5 戦略的展望
15.8 ダナハー社
15.8.1 企業スナップショット
15.8.2 会社概要
15.8.3 財務分析
15.8.4 製品ベンチマーク
15.8.5 戦略的な展望
15.9 アジレント・テクノロジー
15.9.1 企業スナップショット
15.9.2 会社概要
15.9.3 財務分析
15.9.4 製品ベンチマーク
15.9.5 戦略的な展望
15.10 Exact Sciences Corp.
15.10.1 企業スナップショット
15.10.2 会社概要
15.10.3 財務分析
15.10.4 製品ベンチマーク
15.10.5 戦略的展望
15.11 Abacus Diagnostica Oy 【ユニオゲン】
15.11.1 企業スナップショット
15.11.2 会社概要
15.11.3 ベンチマーキング
Rapid GenomEra PCR テスト
15.11.4 戦略的展望
15.12 パーキンエルマー社
15.12.1 企業スナップショット
15.12.2 会社概要
15.12.3 財務分析
15.12.4 製品ベンチマーク
15.12.5 戦略的な展望
15.13 バイオMérieux SA
15.13.1 企業スナップショット
15.13.2 会社概要
15.13.3 財務分析
15.13.4 製品ベンチマーク
15.13.5 戦略的展望
15.14 サーモフィッシャーサイエンティフィック
15.14.1 企業スナップショット
15.14.2 会社概要
15.14.3 財務分析
15.14.4 製品ベンチマーク
15.14.5 戦略的展望

16 結論と提言
16.1 ヴィジョンゲインからの結論
16.2 市場関係者への提言

表の一覧
Table 1 Global Molecular Diagnostics Market Snapshot, 2022 & 2032 (US$ million, CAGR %)
Table 2 Testing Service Provider Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 3 Diagnostic Kit Manufacturers Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 4 OEM Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 5 Software Providers Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 6 Infectious Disease Testing Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 7 Covid-19 Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 8 Hepatitis Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 9 HIV Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 10 CT/NG Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 11 HAI Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 12 HPV Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 13 Tuberculosis Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 14 Influenza Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 15 Others Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 16 Oncology Testing Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 17 Genetic Testing Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 18 Others Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 19 Global Molecular Diagnostics Market Forecast by Therapeutics, 2022-2032 (US$ million, AGR %, CAGR %)
Table 20 Diagnostic Laboratories Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 21 Hospitals & Clinics Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 22 Global Molecular Diagnostics Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 23 Global Molecular Diagnostics Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)): “V” Shaped Recovery Scenario
Table 24 Global Molecular Diagnostics Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)): “U” Shaped Recovery Scenario
Table 25 Global Molecular Diagnostics Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)): “W” Shaped Recovery Scenario
Table 26 Global Molecular Diagnostics Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)): “L” Shaped Recovery Scenario
Table 27 North America Molecular Diagnostics Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR%)
Table 28 North America Molecular Diagnostics Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR%)
Table 29 North America Molecular Diagnostics Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR%)
Table 30 Testing Service Provider Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 31 North America Molecular Diagnostics Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR%)
Table 32 U.S. Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 33 Canada Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 34 Europe Molecular Diagnostics Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR%)
Table 35 Europe Molecular Diagnostics Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR%)
Table 36 Testing Service Provider Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 37 Europe Molecular Diagnostics Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR%)
Table 38 Germany Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 39 France Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 40 UK Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 41 Italy Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 42 Spain Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 43 Russia Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 44 Asia Pacific Molecular Diagnostics Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR%)
Table 45 Asia Pacific Molecular Diagnostics Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR%)
Table 46 Testing Service Provider Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 47 Asia Pacific Molecular Diagnostics Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR%)
Table 48 Japan Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 49 China Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 50 India Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 51 Australia Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 52 South Korea Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 53 Rest of Asia Pacific Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 54 Latin America Molecular Diagnostics Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR%)
Table 55 Latin America Molecular Diagnostics Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR%)
Table 56 Testing Service Provider Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 57 Latin America Molecular Diagnostics Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR%)
Table 58 Brazil Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 59 Mexico Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 60 Middle East & Africa Molecular Diagnostics Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR%)
Table 61 Middle East & Africa Molecular Diagnostics Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR%)
Table 62 Testing Service Provider Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 63 Middle East & Africa Molecular Diagnostics Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR%)
Table 64 GCC Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 65 South Africa Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 66 Key Business Strategies Adopted by Key Players in Global Molecular Diagnostics Market
Table 67 Abbott Laboratories Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 68 Abbott: Product Benchmarking
Table 69 Abbott Laboratories Inc.: Strategic Outlook
Table 70 F. Hoffmann-La Roche Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 71 F. Hoffmann-La Roche Ltd.: Product Benchmarking
Table 72 F. Hoffmann-La Roche Ltd.: Strategic Outlook
Table 73 Hologic Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 74 Hologic Inc.: Product Benchmarking
Table 75 Hologic Inc.: Strategic Outlook
Table 76 Qiagen N.V.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 Qiagen N.V.: Product Benchmarking
Table 78 Qiagen N.V.: Strategic Outlook
Table 79 Becton, Dickinson and Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 80 Becton, Dickinson and Company: Product Benchmarking
Table 81 Becton, Dickinson and Company: Strategic Outlook
Table 82 Cepheid: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 Cepheid: Product Benchmarking
Table 84 Cepheid: Strategic Outlook
Table 85 Siemens Medical Solutions Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 Siemens Medical Solutions Inc.: Product Benchmarking
Table 87 Siemens Medical Solutions Inc.: Strategic Outlook
Table 88 Danaher Corp.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Danaher Corp.: Product Benchmarking
Table 90 Danaher Corp.: Strategic Outlook
Table 91 Agilent Technologies Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Agilent Technologies Inc.: Product Benchmarking
Table 93 Agilent Technologies Inc.: Strategic Outlook
Table 94 Exact Sciences Corp.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Exact Sciences Corp.: Product Benchmarking
Table 96 Exact Sciences Corp.: Strategic Outlook
Table 97 Abacus Diagnostica Oy: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Abacus Diagnostica Oy: Product Benchmarking
Table 99 Abacus Diagnostica Oy: Strategic Outlook
Table 100 PerkinElmer, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 PerkinElmer, Inc.: Product Benchmarking
Table 102 PerkinElmer, Inc.: Strategic Outlook
Table 103 bioMérieux SA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 bioMérieux SA: Product Benchmarking
Table 105 bioMérieux SA: Strategic Outlook
Table 106 Thermo Fisher Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Thermo Fisher Scientific: Product Benchmarking
Table 108 Thermo Fisher Scientific: Strategic Outlook

図の一覧
Figure 1 Global Molecular Diagnostics Market Segmentation
Figure 2 Global Molecular Diagnostics Market Forecast by Type: Market Attractiveness Index
Figure 3 Global Molecular Diagnostics Market by Therapeutics: Market Attractiveness Index
Figure 4 Global Molecular Diagnostics Market by Technology: Market Attractiveness Index
Figure 5 Global Molecular Diagnostics Market by End-users: Market Attractiveness Index
Figure 6 Global Molecular Diagnostics Market: Market Dynamics
Figure 7 Global Molecular Diagnostics Market: Porter’s Five Forces Analysis
Figure 8 Global Molecular Diagnostics Market: PESTEL Analysis
Figure 9 Global Molecular Diagnostics Market Forecast by Type 2022, 2027, 2032 (Revenue, CAGR%)
Figure 10 Global Molecular Diagnostics Market Share Forecast by Type, 2022, 2032 (%)
Figure 11 Testing Service Provider Market Forecast by Region, 2022-2032 (US$ million)
Figure 12 Testing Service Provider Market Share Forecast by Region, 2022-2032 (%)
Figure 13 Diagnostic Kit Manufacturer Market Forecast by Region, 2022-2032 (US$ million)
Figure 14 Diagnostic Kit Manufacturers Market Share Forecast by Region, 2022-2032 (%)
Figure 15 OEM Market Forecast by Region, 2022-2032 (US$ million)
Figure 16 OEM Market Share Forecast by Region, 2022-2032 (%)
Figure 17 Software Providers Market Forecast by Region, 2022-2032 (US$ million)
Figure 18 Software Providers Market Share Forecast by Region, 2022-2032 (%)
Figure 19 Global Molecular Diagnostics Market Forecast by Application 2022, 2027, 2032 (Revenue, CAGR%)
Figure 20 Global Molecular Diagnostics Market Share Forecast by Application, 2022, 2032 (%)
Figure 21 Infectious Disease Testing Market Forecast by Region, 2022-2032 (US$ million)
Figure 22 Infectious Disease Testing Market Share Forecast by Region, 2022-2032 (%)
Figure 23 Covid-19 Market Forecast by Region, 2022-2032 (US$ million)
Figure 24 Covid-19 Market Share Forecast by Region, 2022-2032 (%)
Figure 25 Hepatitis Market Forecast by Region, 2022-2032 (US$ million)
Figure 26 Hepatitis Market Share Forecast by Region, 2022-2032 (%)
Figure 27 HIV Market Forecast by Region, 2022-2032 (US$ million)
Figure 28 HIV Market Share Forecast by Region, 2022-2032 (%)
Figure 29 CT/NG Market Forecast by Region, 2022-2032 (US$ million)
Figure 30 CT/NG Market Share Forecast by Region, 2022-2032 (%)
Figure 31 HAI Market Forecast by Region, 2022-2032 (US$ million)
Figure 32 HAI Market Share Forecast by Region, 2022-2032 (%)
Figure 33 HPV Market Forecast by Region, 2022-2032 (US$ million)
Figure 34 HPV Market Share Forecast by Region, 2022-2032 (%)
Figure 35 Tuberculosis Market Forecast by Region, 2022-2032 (US$ million)
Figure 36 Tuberculosis Market Share Forecast by Region, 2022-2032 (%)
Figure 37 Influenza Market Forecast by Region, 2022-2032 (US$ million)
Figure 38 Influenza Market Share Forecast by Region, 2022-2032 (%)
Figure 39 Others Market Forecast by Region, 2022-2032 (US$ million)
Figure 40 Others Market Share Forecast by Region, 2022-2032 (%)
Figure 41 Oncology Testing Market Forecast by Region, 2022-2032 (US$ million)
Figure 42 Oncology Testing Market Share Forecast by Region, 2022-2032 (%)
Figure 43 Genetic Testing Market Forecast by Region, 2022-2032 (US$ million)
Figure 44 Genetic Testing Market Share Forecast by Region, 2022-2032 (%)
Figure 45 Others Market Forecast by Region, 2022-2032 (US$ million)
Figure 46 Others Market Share Forecast by Region, 2022-2032 (%)
Figure 47 Global Molecular Diagnostics Market Forecast by End User 2022- 2032 (Revenue, CAGR%)
Figure 48 Global Molecular Diagnostics Market Forecast by End User 2022-2032 (US$ million, AGR %)
Figure 49 Global Molecular Diagnostics Market Share Forecast by Type, 2022, 2027, 2032 (%)
Figure 50 Diagnostic Laboratories Market Forecast by Region, 2022-2032 (US$ million)
Figure 51 Diagnostic Laboratories Market Share Forecast by Region, 2022-2032 (%)
Figure 52 Hospitals and Laboratories Market Forecast by Region, 2022-2032 (US$ million)
Figure 53 Hospitals & Clinics Market Share Forecast by Region, 2022-2032 (%)
Figure 54 Global Molecular Diagnostics Market Forecast by Region 2022, 2027, 2032 (Revenue, CAGR%)
Figure 55 Global Molecular Diagnostics Market Share Forecast by Region 2022, 2027, 2032(%)
Figure 56 Global Molecular Diagnostics Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 57 Global Molecular Diagnostics Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 58 Global Molecular Diagnostics Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 59 Global Molecular Diagnostics Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 60 Global Molecular Diagnostics Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 61 North America Molecular Diagnostics Market Attractiveness Index
Figure 62 North America Molecular Diagnostics Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 63 North America Molecular Diagnostics Market Forecast by Country, 2022-2032 (US$ million, AGR %)
Figure 64 North America Molecular Diagnostics Market Share Forecast by Country, 2022 & 2032 (%)
Figure 65 North America Molecular Diagnostics Market Forecast by Type, 2022-2032 (US$ million, AGR %)
Figure 66 North America Molecular Diagnostics Market Share Forecast by Type, 2022 & 2032 (%)
Figure 67 North America Molecular Diagnostics Market Forecast by Application, 2022-2032 (US$ million, AGR %)
Figure 68 North America Molecular Diagnostics Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 69 North America Molecular Diagnostics Market Forecast by End-users, 2022-2032 (US$ million, AGR %)
Figure 70 North America Molecular Diagnostics Market Share Forecast by End-users, 2022 & 2032 (%)
Figure 71 U.S. Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 72 Canada Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 73 Europe Molecular Diagnostics Market Attractiveness Index
Figure 74 Europe Molecular Diagnostics Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 75 Europe Molecular Diagnostics Market Forecast by Country, 2022-2032 (US$ million, AGR %)
Figure 76 Europe Molecular Diagnostics Market Share Forecast by Country, 2022 & 2032 (%)
Figure 77 Europe Molecular Diagnostics Market Forecast by Type, 2022-2032 (US$ million, AGR %)
Figure 78 Europe Molecular Diagnostics Market Share Forecast by Type, 2022 & 2032 (%)
Figure 79 Europe Molecular Diagnostics Market Forecast by Application, 2022-2032 (US$ million, AGR %)
Figure 80 Europe Molecular Diagnostics Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 81 Europe Molecular Diagnostics Market Forecast by End-users, 2022-2032 (US$ million, AGR %)
Figure 82 Europe Molecular Diagnostics Market Share Forecast by End-users, 2022 & 2032 (%)
Figure 83 Germany Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 84 France Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 85 UK Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 86 Italy Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 87 Spain Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 88 Russia Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 89 Asia Pacific Molecular Diagnostics Market Attractiveness Index
Figure 90 Asia Pacific Molecular Diagnostics Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 91 Asia Pacific Molecular Diagnostics Market Forecast by Country, 2022-2032 (US$ million, AGR %)
Figure 92 Asia Pacific Molecular Diagnostics Market Share Forecast by Country, 2022 & 2032 (%)
Figure 93 Asia Pacific Molecular Diagnostics Market Forecast by Type, 2022-2032 (US$ million, AGR %)
Figure 94 Asia Pacific Molecular Diagnostics Market Share Forecast by Type, 2022 & 2032 (%)
Figure 95 Asia Pacific Molecular Diagnostics Market Forecast by Application, 2022-2032 (US$ million, AGR %)
Figure 96 Asia Pacific Molecular Diagnostics Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 97 Asia Pacific Molecular Diagnostics Market Forecast by End-users, 2022-2032 (US$ million, AGR %)
Figure 98 Asia Pacific Molecular Diagnostics Market Share Forecast by End-users, 2022 & 2032 (%)
Figure 99 Japan Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 100 China Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 101 India Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 102 Australia Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 103 South Korea Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 104 Rest of Asia Pacific Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 105 Latin America Molecular Diagnostics Market Attractiveness Index
Figure 106 Latin America Molecular Diagnostics Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 107 Latin America Molecular Diagnostics Market Forecast by Country, 2022-2032 (US$ million, AGR %)
Figure 108 Latin America Molecular Diagnostics Market Share Forecast by Country, 2022 & 2032 (%)
Figure 109 Latin America Molecular Diagnostics Market Forecast by Type, 2022-2032 (US$ million, AGR %)
Figure 110 Latin America Molecular Diagnostics Market Share Forecast by Type, 2022 & 2032 (%)
Figure 111 Latin America Molecular Diagnostics Market Forecast by Application, 2022-2032 (US$ million, AGR %)
Figure 112 Latin America Molecular Diagnostics Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 113 Latin America Molecular Diagnostics Market Forecast by End-users, 2022-2032 (US$ million, AGR %)
Figure 114 Latin America Molecular Diagnostics Market Share Forecast by End-users, 2022 & 2032 (%)
Figure 115 Brazil Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 116 Mexico Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 117 Middle East & Africa Molecular Diagnostics Market Attractiveness Index
Figure 118 Middle East & Africa Molecular Diagnostics Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 119 Middle East & Africa Molecular Diagnostics Market Forecast by Country, 2022-2032 (US$ million, AGR %)
Figure 120 Middle East & Africa Molecular Diagnostics Market Share Forecast by Country, 2022 & 2032 (%)
Figure 121 Middle East & Africa Molecular Diagnostics Market Forecast by Type, 2022-2032 (US$ million, AGR %)
Figure 122 Middle East & Africa Molecular Diagnostics Market Share Forecast by Type, 2022 & 2032 (%)
Figure 123 Middle East & Africa Molecular Diagnostics Market Forecast by Application, 2022-2032 (US$ million, AGR %)
Figure 124 Middle East & Africa Molecular Diagnostics Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 125 Middle East & Africa Molecular Diagnostics Market Forecast by End-users, 2022-2032 (US$ million, AGR %)
Figure 126 Middle East & Africa Molecular Diagnostics Market Share Forecast by End-users, 2022 & 2032 (%)
Figure 127 GCC Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 128 South Africa Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 129 Global Molecular Diagnostics Market: Company Share Analysis, 2021
Figure 130 Abbott Laboratories Inc.: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 131 Abbott Laboratories Inc.: Regional Market Shares, 2021
Figure 132 Abbott Laboratories Inc.: Gross Profit, 2016-2021 (US$ million, AGR%)
Figure 133 Abbott Laboratories Inc.: R&D, 2016-2021 (US$ million, AGR%)
Figure 134 F. Hoffmann-La Roche Ltd.: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 135 F. Hoffmann-La Roche Ltd.: Regional Market Shares, 2021
Figure 136 F. Hoffmann-La Roche Ltd.: Operating Profit, 2016-2021 (US$ million, AGR%)
Figure 137 F. Hoffmann-La Roche Ltd.: R&D, 2016-2021 (US$ million, AGR%)
Figure 138 Hologic Inc.: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 139 Hologic Inc.: Regional Market Shares, 2021
Figure 140 Hologic Inc.: Gross Profit, 2016-2021 (US$ million, AGR%)
Figure 141 Hologic Inc.: R&D, 2016-2021 (US$ million, AGR%)
Figure 142 Qiagen N.V.: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 143 Qiagen N.V.: Regional Market Shares, 2021
Figure 144 Qiagen N.V.: Gross Profit, 2016-2021 (US$ million, AGR%)
Figure 145 Qiagen N.V.: R&D, 2016-2021 (US$ million, AGR%)
Figure 146 Becton, Dickinson and Company: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 147 Becton, Dickinson and Company: Regional Market Shares, 2021
Figure 148 Becton, Dickinson and Company: Gross Profit, 2016-2021 (US$ million, AGR%)
Figure 149 Becton, Dickinson and Company: R&D, 2016-2019 (US$ million, AGR%)
Figure 150 Siemens Medical Solutions Inc.: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 151 Siemens Medical Solutions Inc.: Gross Profit, 2016-2021 (US$ million, AGR%)
Figure 152 Siemens Medical Solutions Inc.: R&D, 2016-2021 (US$ million, AGR%)
Figure 153 Danaher Corp.: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 154 Danaher Corp.: Regional Market Shares, 2021
Figure 155 Danaher Corp.: Gross Profit, 2016-2021 (US$ million, AGR%)
Figure 156 Agilent Technologies Inc.: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 157 Agilent Technologies Inc.: Regional Market Shares, 2021
Figure 158 Agilent Technologies Inc.: Gross Profit, 2016-2021 (US$ million, AGR%)
Figure 159 Agilent Technologies Inc.: R&D, 2016-2021 (US$ million, AGR%)
Figure 160 Exact Sciences Corp.: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 161 Exact Sciences Corp.: Gross Profit, 2016-2021 (US$ million, AGR%)
Figure 162 Exact Sciences Corp.: R&D, 2016-2021 (US$ million, AGR%)
Figure 163 PerkinElmer, Inc.: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 164 PerkinElmer, Inc.: Regional Market Shares, 2020
Figure 165 PerkinElmer, Inc.: Gross Profit, 2016-2021 (US$ million, AGR%)
Figure 166 PerkinElmer, Inc.: R&D, 2016-2021 (US$ million, AGR%)
Figure 167 bioMérieux SA: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 168 bioMérieux SA: Regional Market Shares, 2019
Figure 169 bioMérieux SA: Gross Profit, 2016-2019 (US$ million, AGR%)
Figure 170 bioMérieux SA: R&D, 2016-2019 (US$ million, AGR%)
Figure 171 Thermo Fisher Scientific: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 172 Thermo Fisher Scientific: Regional Market Shares, 2021
Figure 173 Thermo Fisher Scientific: Gross Profit, 2016-2021 (US$ million, AGR%)
Figure 174 Thermo Fisher Scientific: R&D, 2016-2021 (US$ million, AGR%)

ページTOPに戻る

Table of Contents

Summary

この調査レポートは世界の分子診断薬（MDx）市場を調査し、タイプ別、用途別、エンドユーザー別、地域別に2022年から2032年までの予測結果を掲載しています。また関連企業情報を提供しています。

主な掲載内容（目次より抜粋）

レポート概要
エグゼクティブサマリー
プレミアムインサイト
市場概要
世界の分子診断薬市場分析：タイプ別
世界の分子診断薬市場分析：用途別
世界の分子診断薬市場分析：エンドユーザー別
世界の分子診断薬市場分析：地域別
北米の分子診断薬市場分析
欧州の分子診断薬市場分析
アジア太平洋地域の分子診断薬市場分析
ラテンアメリカの分子診断薬市場分析
中東・アフリカの分子診断薬市場分析
競争状況
主要企業のプロフィール

Report Details

The Molecular Diagnostics (MDx) Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Growing Need for Point of Care Diagnostics is One of The Key Factor Driving the Market Growth
Portable molecular diagnostics include assays and kits used to detect and diagnose diseases in human samples such as throat swabs, blood, serum, and stool. Molecular diagnostics are moving away from centralised laboratories and toward point-of-care molecular testing.

Point-of-care testing, also known as POC testing, is a type of medical testing done at or near the point of care. POC indicates the site of the patient. Sending all samples and specimens away to be processed at medical laboratories means waiting a long time for results. POC tests can greatly improve the management of infectious diseases, especially in developing countries where access to timely medical care faces numerous challenges and the healthcare infrastructure is still old.

The rising prevalence of various diseases has accelerated the development of point-of-care testing methods, fueling the growth of the molecular diagnosis market. According to UNAIDS Data of 2020, approximately 20.6 million people in East and Southern Africa were living with HIV in 2018. In the Middle East and North Africa in 2019, 20,000 new HIV cases were reported.

In 2019, an estimated 5.8 million people in Asia Pacific were infected with HIV, with India and China leading the way. According to UNAIDS, approximately 2.1 million people in India were HIV-positive in 2019. The high prevalence of HIV is expected to increase demand for point-of-care diagnostics, hastening the treatment of HIV infection.

Rising number of vaccinations globally along with higher prices of molecular tests
The COVID-19 outbreak sparked a race in the diagnostics industry to create novel and rapid coronavirus detection kits. Companies in the infectious diseases segment saw an increase in revenue as a result of the pandemic. For example, Thermo Fisher Scientific reported a 59 percent increase in revenue in April 2021, owing to a 150 percent increase in the diagnostics division. However, as global vaccination rates increase, demand for COVID-19 diagnostics is expected to decrease during the forecast period.

Molecular diagnostics provides precise and effective results and has critical applications in disease diagnosis. However, one of the major impediments to this market is the high cost of molecular tests.

What Questions Should You Ask before Buying a Market Research Report?
• How is the molecular diagnostics market evolving?
• What is driving and restraining the molecular diagnostics market?
• How will each molecular diagnostic submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
• How will the market shares for each molecular diagnostics submarket develop from 2022 to 2032?
• What will be the main driver for the overall market from 2022 to 2032?
• Will leading molecular diagnostics markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
• Who are the leading players and what are their prospects over the forecast period?
• What are the molecular diagnostics projects for these leading companies?
• How will the industry evolve during the period between 2020 and 2032? What are the implications of molecular diagnostics projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the molecular diagnostics market?
• Where is the molecular diagnostics market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the molecular diagnostics market today, and over the next 10 years:
• Our 236-page report provides 106 tables and 173 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the molecular diagnostics market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

The report delivers exclusive COVID-19 variations and economic data specific to your market.

Forecasts to 2032 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising molecular diagnostics prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Type Outlook
• Testing service provider
• Diagnostic Manufacturers
• OEM
• Software Providers

Application
• Infectious Disease Diagnostics
– COVID-19
– Hepatitis
– HIV
– CT/NG
– HAI
– HPV
– Tuberculosis
– Influenza
– Others
• Oncology Testing
• Genetic Tests
• Others

End User
• Diagnostic Laboratories
• Hospitals and Clinics
• Other End Users

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:

North America
• U.S.
• Canada
• Mexico

Europe
• Germany
• Spain
• United Kingdom
• France
• Italy
• Rest of Europe

Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

LAMEA
• Brazil
• Turkey
• Saudi Arabia
• South Africa
• UAE
• Rest of Latin America

The report also includes profiles and for some of the leading companies in the Molecular Diagnostics Market, 2022 to 2032, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• Abbott Laboratories Inc
• F. Hoffmann-La Roche Ltd.
• Hologic Inc.
• Qiagen N.V.
• Becton, Dickinson and Company
• Cepheid
• Siemens Medical Solutions Inc.
• Danaher Corp.
• Agilent Technologies Inc.
• Exact Sciences Corp
• Abacus Diagnostica Oy [Uniogen] • PerkinElmer, Inc.
• bioMérieux SA
• Thermo Fisher Scientific

Overall world revenue for Molecular Diagnostics Market, 2022 to 2032 in terms of value the market will surpass US$23,498.2 million in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Molecular Diagnostics Market, 2022 to 2032 report help you?
In summary, our 230+ page report provides you with the following knowledge:

• Revenue forecasts to 2032 for Molecular Diagnostics Market, 2022 to 2032 Market, with forecasts for process, upstream, downstream, type and company size, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2032 for four regional and 20 key national markets – See forecasts for the Molecular Diagnostics Market, 2022 to 2032 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for 20 of the major companies involved in the Molecular Diagnostics Market, 2022 to 2032.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Molecular Diagnostics Market, 2022 to 2032, market-leading companies. You will find data, trends and predictions.

ページTOPに戻る

Table of Contents

1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Molecular Diagnostics Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by the Analytical Report Include:
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Premium Insights
3.1 Type Snapshot: Global Molecular Diagnostics Market
3.2 Application Segment: Market Attractiveness Index
3.3 End User Segment: Market Attractiveness Index
3.4 Regional Segment: Market Attractiveness Index

4 Market Overview
4.1 Key Findings
4.2 Market Dynamics
4.2.1 Market Driving Factors
4.2.2 Market Restraining Factors
4.2.3 Market Opportunities
4.3 Porter’s Five Forces Analysis
4.3.1 Supplier Power
4.3.2 Buyer Power
4.3.3 Competitive Rivalry
4.3.4 Threat from Substitutes
4.3.5 Threat of New Entrants
4.4 PESTEL Analysis

5 Global Molecular Diagnostics Market Analysis by Type
5.1 Key Findings
5.2 Type Segment Growth Prospects
5.3 Global Molecular Diagnostics Market Share by Type, 2022 & 2032
5.4 Testing Service Provider
5.4.1 Testing Service Provider Market Forecast by Region, 2022-2032 (US$ Mn)
5.4.2 Testing Service Provider Market Share by Region, 2022-2032 (%)
5.5 Diagnostic Kit Manufacturers
5.5.1 Diagnostic Kit Manufacturers Market Forecast by Region, 2022-2032 (US$ Mn)
5.5.2 Diagnostic Kit Manufacturers Market Share by Region, 2022-2032 (%)
5.6 OEM
5.6.1 OEM Market Forecast by Region, 2022-2032 (US$ Mn)
5.6.2 OEM Market Share by Region, 2022-2032 (%)
5.7 Software Providers
5.7.1 Software Providers Market Forecast by Region, 2022-2032 (US$ Mn)
5.7.2 Software Providers Market Share by Region, 2022-2032 (%)

6 Global Molecular Diagnostics Market Analysis by Application
6.1 Key Findings
6.2 Application Segment Growth Prospects
6.3 Global Molecular Diagnostics Market Share by Application, 2022 & 2032
6.4 Infectious Disease Testing
6.4.1 Infectious Disease Testing Market Forecast by Region, 2022-2032 (US$ Mn)
6.4.2 Infectious Disease Testing Market Share by Region, 2022-2032 (%)
6.4.3 HIV Market Share by Region, 2022-2032 (%)
6.4.4 CT/NG Market Share by Region, 2022-2032 (%)
6.4.5 HAI Market Share by Region, 2022-2032 (%)
6.4.6 Influenza Market Share by Region, 2022-2032 (%)
6.5 Oncology Testing
6.5.1 Oncology Testing Market Forecast by Region, 2022-2032 (US$ Mn)
6.5.2 Oncology Testing Market Share by Region, 2022-2032 (%)
6.6 Genetic Testing
6.6.1 Genetic Testing Market Forecast by Region, 2022-2032 (US$ Mn)
6.6.2 Genetic Testing Market Share by Region, 2022-2032 (%)
6.7 Others
6.7.1 Others Market Forecast by Region, 2022-2032 (US$ Mn)
6.7.2 Others Market Share by Region, 2022-2032 (%)

7 Global Molecular Diagnostics Market Analysis by End User
7.1.1 Key Findings
7.1.2 End User Segment Growth Prospects
7.2 Global Molecular Diagnostics Market Size Estimation and Forecast by End User
7.3 Diagnostic Laboratories
7.3.1 Diagnostic Laboratories Market Forecast by Region, 2022-2032 (US$ Mn)
7.3.2 Diagnostic Laboratories Market Share by Region, 2022-2032 (%)
7.4 Hospitals & Clinics
7.4.1 Hospitals & Clinics Market Forecast by Region, 2022-2032 (US$ Mn)
7.4.2 Hospitals & Clinics Market Share by Region, 2022-2032 (%)

8 Global Molecular Diagnostics Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast
8.3 COVID-19 Impact Analysis

9 North America Molecular Diagnostics Market Analysis
9.1 Key Findings
9.2 North America Molecular Diagnostics Market Attractiveness Index
9.3 North America Molecular Diagnostics Market by Country, 2022, 2027 & 2032 (US$ Mn)
9.4 North America Molecular Diagnostics Market Size Estimation and Forecast by Country
9.5 North America Molecular Diagnostics Market Size Estimation and Forecast by Type
9.6 North America Molecular Diagnostics Market Size Estimation and Forecast by Application
9.7 North America Molecular Diagnostics Market Size Estimation and Forecast by End-users
9.8 U.S.
9.9 Canada

10 Europe Molecular Diagnostics Market Analysis
10.1 Key Findings
10.2 Europe Molecular Diagnostics Market Attractiveness Index
10.3 Europe Molecular Diagnostics Market by Country, 2022, 2027 & 2032 (US$ Mn)
10.4 Europe Molecular Diagnostics Market Size Estimation and Forecast by Country
10.5 Europe Molecular Diagnostics Market Size Estimation and Forecast by Type
10.6 Europe Molecular Diagnostics Market Size Estimation and Forecast by Application
10.7 Europe Molecular Diagnostics Market Size Estimation and Forecast by End-users
10.8 Germany
10.9 France
10.10 UK
10.11 Italy
10.12 Spain
10.13 Russia

11 Asia Pacific Molecular Diagnostics Market Analysis
11.1 Key Findings
11.2 Asia Pacific Molecular Diagnostics Market Attractiveness Index
11.3 Asia Pacific Molecular Diagnostics Market by Country, 2022, 2027 & 2032 (US$ Mn)
11.4 Asia Pacific Molecular Diagnostics Market Size Estimation and Forecast by Country
11.5 Asia Pacific Molecular Diagnostics Market Size Estimation and Forecast by Type
11.6 Asia Pacific Molecular Diagnostics Market Size Estimation and Forecast by Application
11.7 Asia Pacific Molecular Diagnostics Market Size Estimation and Forecast by End-users
11.8 Japan
11.9 China
11.10 India
11.11 Australia
11.12 South Korea
11.13 Rest of Asia Pacific

12 Latin America Molecular Diagnostics Market Analysis
12.1 Key Findings
12.2 Latin America Molecular Diagnostics Market Attractiveness Index
12.3 Latin America Molecular Diagnostics Market by Country, 2022, 2027 & 2032 (US$ million)
12.4 Latin America Molecular Diagnostics Market Size Estimation and Forecast by Country
12.5 Latin America Molecular Diagnostics Market Size Estimation and Forecast by Type
12.6 Latin America Molecular Diagnostics Market Size Estimation and Forecast by Application
12.7 Latin America Molecular Diagnostics Market Size Estimation and Forecast by End-users
12.8 Brazil
12.9 Mexico

13 Middle East & Africa Molecular Diagnostics Market Analysis
13.1 Key Findings
13.2 Middle East & Africa Molecular Diagnostics Market Attractiveness Index
13.3 Middle East & Africa Molecular Diagnostics Market by Country, 2022, 2027 & 2032 (US$ Mn)
13.4 Middle East & Africa Molecular Diagnostics Market Size Estimation and Forecast by Country
13.5 Middle East & Africa Molecular Diagnostics Market Size Estimation and Forecast by Type
13.6 Middle East & Africa Molecular Diagnostics Market Size Estimation and Forecast by Application
13.7 Middle East & Africa Molecular Diagnostics Market Size Estimation and Forecast by End-users
13.8 GCC
13.9 South Africa

14 Competitive Landscape
14.1 Company Share Analysis
14.2 Key Business Strategy Analysis

15 Company Profiles
15.1 Abbott Laboratories Inc.
15.1.1 Company Snapshot
15.1.2 Company Overview
15.1.3 Financial Analysis
15.1.4 Product Benchmarking
15.1.5 Strategic Outlook
15.2 F. Hoffmann-La Roche Ltd.
15.2.1 Company Snapshot
15.2.2 Company Overview
15.2.3 Financial Analysis
15.2.4 Product Benchmarking
15.2.5 Strategic Outlook
15.3 Hologic Inc.
15.3.1 Company Snapshot
15.3.2 Company Overview
15.3.3 Financial Analysis
15.3.4 Product Benchmarking
15.3.5 Strategic Outlook
15.4 Qiagen N.V.
15.4.1 Company Snapshot
15.4.2 Company Overview
15.4.3 Financial Analysis
15.4.4 Product Benchmarking
15.4.5 Strategic Outlook
15.5 Becton, Dickinson and Company
15.5.1 Company Snapshot
15.5.2 Company Overview
15.5.3 Financial Analysis
15.5.4 Product Benchmarking
15.5.5 Strategic Outlook
15.6 Cepheid
15.6.1 Company Snapshot
15.6.2 Company Overview
15.6.3 Product Benchmarking
15.6.4 Strategic Outlook
15.7 Siemens Medical Solutions Inc.
15.7.1 Company Snapshot
15.7.2 Company Overview
15.7.3 Financial Analysis
15.7.4 Product Benchmarking
15.7.5 Strategic Outlook
15.8 Danaher Corp.
15.8.1 Company Snapshot
15.8.2 Company Overview
15.8.3 Financial Analysis
15.8.4 Product Benchmarking
15.8.5 Strategic Outlook
15.9 Agilent Technologies Inc.
15.9.1 Company Snapshot
15.9.2 Company Overview
15.9.3 Financial Analysis
15.9.4 Product Benchmarking
15.9.5 Strategic Outlook
15.10 Exact Sciences Corp.
15.10.1 Company Snapshot
15.10.2 Company Overview
15.10.3 Financial Analysis
15.10.4 Product Benchmarking
15.10.5 Strategic Outlook
15.11 Abacus Diagnostica Oy [Uniogen]
15.11.1 Company Snapshot
15.11.2 Company Overview
15.11.3 Product Benchmarking
Rapid GenomEra PCR tests
15.11.4 Strategic Outlook
15.12 PerkinElmer, Inc.
15.12.1 Company Snapshot
15.12.2 Company Overview
15.12.3 Financial Analysis
15.12.4 Product Benchmarking
15.12.5 Strategic Outlook
15.13 bioMérieux SA
15.13.1 Company Snapshot
15.13.2 Company Overview
15.13.3 Financial Analysis
15.13.4 Product Benchmarking
15.13.5 Strategic Outlook
15.14 Thermo Fisher Scientific
15.14.1 Company Snapshot
15.14.2 Company Overview
15.14.3 Financial Analysis
15.14.4 Product Benchmarking
15.14.5 Strategic Outlook

16 Conclusion and Recommendations
16.1 Concluding Remarks from Visiongain
16.2 Recommendations for Market Players

List of Tables
Table 1 Global Molecular Diagnostics Market Snapshot, 2022 & 2032 (US$ million, CAGR %)
Table 2 Testing Service Provider Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 3 Diagnostic Kit Manufacturers Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 4 OEM Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 5 Software Providers Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 6 Infectious Disease Testing Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 7 Covid-19 Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 8 Hepatitis Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 9 HIV Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 10 CT/NG Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 11 HAI Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 12 HPV Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 13 Tuberculosis Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 14 Influenza Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 15 Others Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 16 Oncology Testing Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 17 Genetic Testing Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 18 Others Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 19 Global Molecular Diagnostics Market Forecast by Therapeutics, 2022-2032 (US$ million, AGR %, CAGR %)
Table 20 Diagnostic Laboratories Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 21 Hospitals & Clinics Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 22 Global Molecular Diagnostics Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Table 23 Global Molecular Diagnostics Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)): “V” Shaped Recovery Scenario
Table 24 Global Molecular Diagnostics Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)): “U” Shaped Recovery Scenario
Table 25 Global Molecular Diagnostics Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)): “W” Shaped Recovery Scenario
Table 26 Global Molecular Diagnostics Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)): “L” Shaped Recovery Scenario
Table 27 North America Molecular Diagnostics Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR%)
Table 28 North America Molecular Diagnostics Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR%)
Table 29 North America Molecular Diagnostics Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR%)
Table 30 Testing Service Provider Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 31 North America Molecular Diagnostics Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR%)
Table 32 U.S. Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 33 Canada Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 34 Europe Molecular Diagnostics Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR%)
Table 35 Europe Molecular Diagnostics Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR%)
Table 36 Testing Service Provider Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 37 Europe Molecular Diagnostics Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR%)
Table 38 Germany Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 39 France Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 40 UK Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 41 Italy Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 42 Spain Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 43 Russia Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 44 Asia Pacific Molecular Diagnostics Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR%)
Table 45 Asia Pacific Molecular Diagnostics Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR%)
Table 46 Testing Service Provider Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 47 Asia Pacific Molecular Diagnostics Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR%)
Table 48 Japan Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 49 China Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 50 India Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 51 Australia Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 52 South Korea Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 53 Rest of Asia Pacific Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 54 Latin America Molecular Diagnostics Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR%)
Table 55 Latin America Molecular Diagnostics Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR%)
Table 56 Testing Service Provider Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 57 Latin America Molecular Diagnostics Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR%)
Table 58 Brazil Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 59 Mexico Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 60 Middle East & Africa Molecular Diagnostics Market Forecast by Country, 2022-2032 (US$ million, AGR%, CAGR%)
Table 61 Middle East & Africa Molecular Diagnostics Market Forecast by Type, 2022-2032 (US$ million, AGR%, CAGR%)
Table 62 Testing Service Provider Market Forecast by Region, 2022-2032 (US$ million, AGR%, CAGR%)
Table 63 Middle East & Africa Molecular Diagnostics Market Forecast by End-users, 2022-2032 (US$ million, AGR%, CAGR%)
Table 64 GCC Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 65 South Africa Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR%, CAGR%)
Table 66 Key Business Strategies Adopted by Key Players in Global Molecular Diagnostics Market
Table 67 Abbott Laboratories Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 68 Abbott: Product Benchmarking
Table 69 Abbott Laboratories Inc.: Strategic Outlook
Table 70 F. Hoffmann-La Roche Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 71 F. Hoffmann-La Roche Ltd.: Product Benchmarking
Table 72 F. Hoffmann-La Roche Ltd.: Strategic Outlook
Table 73 Hologic Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 74 Hologic Inc.: Product Benchmarking
Table 75 Hologic Inc.: Strategic Outlook
Table 76 Qiagen N.V.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 Qiagen N.V.: Product Benchmarking
Table 78 Qiagen N.V.: Strategic Outlook
Table 79 Becton, Dickinson and Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 80 Becton, Dickinson and Company: Product Benchmarking
Table 81 Becton, Dickinson and Company: Strategic Outlook
Table 82 Cepheid: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 Cepheid: Product Benchmarking
Table 84 Cepheid: Strategic Outlook
Table 85 Siemens Medical Solutions Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 Siemens Medical Solutions Inc.: Product Benchmarking
Table 87 Siemens Medical Solutions Inc.: Strategic Outlook
Table 88 Danaher Corp.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Danaher Corp.: Product Benchmarking
Table 90 Danaher Corp.: Strategic Outlook
Table 91 Agilent Technologies Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Agilent Technologies Inc.: Product Benchmarking
Table 93 Agilent Technologies Inc.: Strategic Outlook
Table 94 Exact Sciences Corp.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Exact Sciences Corp.: Product Benchmarking
Table 96 Exact Sciences Corp.: Strategic Outlook
Table 97 Abacus Diagnostica Oy: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Abacus Diagnostica Oy: Product Benchmarking
Table 99 Abacus Diagnostica Oy: Strategic Outlook
Table 100 PerkinElmer, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 PerkinElmer, Inc.: Product Benchmarking
Table 102 PerkinElmer, Inc.: Strategic Outlook
Table 103 bioMérieux SA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 bioMérieux SA: Product Benchmarking
Table 105 bioMérieux SA: Strategic Outlook
Table 106 Thermo Fisher Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Thermo Fisher Scientific: Product Benchmarking
Table 108 Thermo Fisher Scientific: Strategic Outlook

List of Figures
Figure 1 Global Molecular Diagnostics Market Segmentation
Figure 2 Global Molecular Diagnostics Market Forecast by Type: Market Attractiveness Index
Figure 3 Global Molecular Diagnostics Market by Therapeutics: Market Attractiveness Index
Figure 4 Global Molecular Diagnostics Market by Technology: Market Attractiveness Index
Figure 5 Global Molecular Diagnostics Market by End-users: Market Attractiveness Index
Figure 6 Global Molecular Diagnostics Market: Market Dynamics
Figure 7 Global Molecular Diagnostics Market: Porter’s Five Forces Analysis
Figure 8 Global Molecular Diagnostics Market: PESTEL Analysis
Figure 9 Global Molecular Diagnostics Market Forecast by Type 2022, 2027, 2032 (Revenue, CAGR%)
Figure 10 Global Molecular Diagnostics Market Share Forecast by Type, 2022, 2032 (%)
Figure 11 Testing Service Provider Market Forecast by Region, 2022-2032 (US$ million)
Figure 12 Testing Service Provider Market Share Forecast by Region, 2022-2032 (%)
Figure 13 Diagnostic Kit Manufacturer Market Forecast by Region, 2022-2032 (US$ million)
Figure 14 Diagnostic Kit Manufacturers Market Share Forecast by Region, 2022-2032 (%)
Figure 15 OEM Market Forecast by Region, 2022-2032 (US$ million)
Figure 16 OEM Market Share Forecast by Region, 2022-2032 (%)
Figure 17 Software Providers Market Forecast by Region, 2022-2032 (US$ million)
Figure 18 Software Providers Market Share Forecast by Region, 2022-2032 (%)
Figure 19 Global Molecular Diagnostics Market Forecast by Application 2022, 2027, 2032 (Revenue, CAGR%)
Figure 20 Global Molecular Diagnostics Market Share Forecast by Application, 2022, 2032 (%)
Figure 21 Infectious Disease Testing Market Forecast by Region, 2022-2032 (US$ million)
Figure 22 Infectious Disease Testing Market Share Forecast by Region, 2022-2032 (%)
Figure 23 Covid-19 Market Forecast by Region, 2022-2032 (US$ million)
Figure 24 Covid-19 Market Share Forecast by Region, 2022-2032 (%)
Figure 25 Hepatitis Market Forecast by Region, 2022-2032 (US$ million)
Figure 26 Hepatitis Market Share Forecast by Region, 2022-2032 (%)
Figure 27 HIV Market Forecast by Region, 2022-2032 (US$ million)
Figure 28 HIV Market Share Forecast by Region, 2022-2032 (%)
Figure 29 CT/NG Market Forecast by Region, 2022-2032 (US$ million)
Figure 30 CT/NG Market Share Forecast by Region, 2022-2032 (%)
Figure 31 HAI Market Forecast by Region, 2022-2032 (US$ million)
Figure 32 HAI Market Share Forecast by Region, 2022-2032 (%)
Figure 33 HPV Market Forecast by Region, 2022-2032 (US$ million)
Figure 34 HPV Market Share Forecast by Region, 2022-2032 (%)
Figure 35 Tuberculosis Market Forecast by Region, 2022-2032 (US$ million)
Figure 36 Tuberculosis Market Share Forecast by Region, 2022-2032 (%)
Figure 37 Influenza Market Forecast by Region, 2022-2032 (US$ million)
Figure 38 Influenza Market Share Forecast by Region, 2022-2032 (%)
Figure 39 Others Market Forecast by Region, 2022-2032 (US$ million)
Figure 40 Others Market Share Forecast by Region, 2022-2032 (%)
Figure 41 Oncology Testing Market Forecast by Region, 2022-2032 (US$ million)
Figure 42 Oncology Testing Market Share Forecast by Region, 2022-2032 (%)
Figure 43 Genetic Testing Market Forecast by Region, 2022-2032 (US$ million)
Figure 44 Genetic Testing Market Share Forecast by Region, 2022-2032 (%)
Figure 45 Others Market Forecast by Region, 2022-2032 (US$ million)
Figure 46 Others Market Share Forecast by Region, 2022-2032 (%)
Figure 47 Global Molecular Diagnostics Market Forecast by End User 2022- 2032 (Revenue, CAGR%)
Figure 48 Global Molecular Diagnostics Market Forecast by End User 2022-2032 (US$ million, AGR %)
Figure 49 Global Molecular Diagnostics Market Share Forecast by Type, 2022, 2027, 2032 (%)
Figure 50 Diagnostic Laboratories Market Forecast by Region, 2022-2032 (US$ million)
Figure 51 Diagnostic Laboratories Market Share Forecast by Region, 2022-2032 (%)
Figure 52 Hospitals and Laboratories Market Forecast by Region, 2022-2032 (US$ million)
Figure 53 Hospitals & Clinics Market Share Forecast by Region, 2022-2032 (%)
Figure 54 Global Molecular Diagnostics Market Forecast by Region 2022, 2027, 2032 (Revenue, CAGR%)
Figure 55 Global Molecular Diagnostics Market Share Forecast by Region 2022, 2027, 2032(%)
Figure 56 Global Molecular Diagnostics Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%))
Figure 57 Global Molecular Diagnostics Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 58 Global Molecular Diagnostics Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 59 Global Molecular Diagnostics Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 60 Global Molecular Diagnostics Market by Region, 2022-2032 (USD Mn, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 61 North America Molecular Diagnostics Market Attractiveness Index
Figure 62 North America Molecular Diagnostics Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 63 North America Molecular Diagnostics Market Forecast by Country, 2022-2032 (US$ million, AGR %)
Figure 64 North America Molecular Diagnostics Market Share Forecast by Country, 2022 & 2032 (%)
Figure 65 North America Molecular Diagnostics Market Forecast by Type, 2022-2032 (US$ million, AGR %)
Figure 66 North America Molecular Diagnostics Market Share Forecast by Type, 2022 & 2032 (%)
Figure 67 North America Molecular Diagnostics Market Forecast by Application, 2022-2032 (US$ million, AGR %)
Figure 68 North America Molecular Diagnostics Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 69 North America Molecular Diagnostics Market Forecast by End-users, 2022-2032 (US$ million, AGR %)
Figure 70 North America Molecular Diagnostics Market Share Forecast by End-users, 2022 & 2032 (%)
Figure 71 U.S. Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 72 Canada Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 73 Europe Molecular Diagnostics Market Attractiveness Index
Figure 74 Europe Molecular Diagnostics Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 75 Europe Molecular Diagnostics Market Forecast by Country, 2022-2032 (US$ million, AGR %)
Figure 76 Europe Molecular Diagnostics Market Share Forecast by Country, 2022 & 2032 (%)
Figure 77 Europe Molecular Diagnostics Market Forecast by Type, 2022-2032 (US$ million, AGR %)
Figure 78 Europe Molecular Diagnostics Market Share Forecast by Type, 2022 & 2032 (%)
Figure 79 Europe Molecular Diagnostics Market Forecast by Application, 2022-2032 (US$ million, AGR %)
Figure 80 Europe Molecular Diagnostics Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 81 Europe Molecular Diagnostics Market Forecast by End-users, 2022-2032 (US$ million, AGR %)
Figure 82 Europe Molecular Diagnostics Market Share Forecast by End-users, 2022 & 2032 (%)
Figure 83 Germany Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 84 France Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 85 UK Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 86 Italy Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 87 Spain Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 88 Russia Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 89 Asia Pacific Molecular Diagnostics Market Attractiveness Index
Figure 90 Asia Pacific Molecular Diagnostics Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 91 Asia Pacific Molecular Diagnostics Market Forecast by Country, 2022-2032 (US$ million, AGR %)
Figure 92 Asia Pacific Molecular Diagnostics Market Share Forecast by Country, 2022 & 2032 (%)
Figure 93 Asia Pacific Molecular Diagnostics Market Forecast by Type, 2022-2032 (US$ million, AGR %)
Figure 94 Asia Pacific Molecular Diagnostics Market Share Forecast by Type, 2022 & 2032 (%)
Figure 95 Asia Pacific Molecular Diagnostics Market Forecast by Application, 2022-2032 (US$ million, AGR %)
Figure 96 Asia Pacific Molecular Diagnostics Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 97 Asia Pacific Molecular Diagnostics Market Forecast by End-users, 2022-2032 (US$ million, AGR %)
Figure 98 Asia Pacific Molecular Diagnostics Market Share Forecast by End-users, 2022 & 2032 (%)
Figure 99 Japan Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 100 China Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 101 India Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 102 Australia Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 103 South Korea Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 104 Rest of Asia Pacific Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 105 Latin America Molecular Diagnostics Market Attractiveness Index
Figure 106 Latin America Molecular Diagnostics Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 107 Latin America Molecular Diagnostics Market Forecast by Country, 2022-2032 (US$ million, AGR %)
Figure 108 Latin America Molecular Diagnostics Market Share Forecast by Country, 2022 & 2032 (%)
Figure 109 Latin America Molecular Diagnostics Market Forecast by Type, 2022-2032 (US$ million, AGR %)
Figure 110 Latin America Molecular Diagnostics Market Share Forecast by Type, 2022 & 2032 (%)
Figure 111 Latin America Molecular Diagnostics Market Forecast by Application, 2022-2032 (US$ million, AGR %)
Figure 112 Latin America Molecular Diagnostics Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 113 Latin America Molecular Diagnostics Market Forecast by End-users, 2022-2032 (US$ million, AGR %)
Figure 114 Latin America Molecular Diagnostics Market Share Forecast by End-users, 2022 & 2032 (%)
Figure 115 Brazil Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 116 Mexico Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 117 Middle East & Africa Molecular Diagnostics Market Attractiveness Index
Figure 118 Middle East & Africa Molecular Diagnostics Market by Region, 2022, 2027 & 2032 (US$ million)
Figure 119 Middle East & Africa Molecular Diagnostics Market Forecast by Country, 2022-2032 (US$ million, AGR %)
Figure 120 Middle East & Africa Molecular Diagnostics Market Share Forecast by Country, 2022 & 2032 (%)
Figure 121 Middle East & Africa Molecular Diagnostics Market Forecast by Type, 2022-2032 (US$ million, AGR %)
Figure 122 Middle East & Africa Molecular Diagnostics Market Share Forecast by Type, 2022 & 2032 (%)
Figure 123 Middle East & Africa Molecular Diagnostics Market Forecast by Application, 2022-2032 (US$ million, AGR %)
Figure 124 Middle East & Africa Molecular Diagnostics Market Share Forecast by Technology, 2022 & 2032 (%)
Figure 125 Middle East & Africa Molecular Diagnostics Market Forecast by End-users, 2022-2032 (US$ million, AGR %)
Figure 126 Middle East & Africa Molecular Diagnostics Market Share Forecast by End-users, 2022 & 2032 (%)
Figure 127 GCC Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 128 South Africa Molecular Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %)
Figure 129 Global Molecular Diagnostics Market: Company Share Analysis, 2021
Figure 130 Abbott Laboratories Inc.: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 131 Abbott Laboratories Inc.: Regional Market Shares, 2021
Figure 132 Abbott Laboratories Inc.: Gross Profit, 2016-2021 (US$ million, AGR%)
Figure 133 Abbott Laboratories Inc.: R&D, 2016-2021 (US$ million, AGR%)
Figure 134 F. Hoffmann-La Roche Ltd.: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 135 F. Hoffmann-La Roche Ltd.: Regional Market Shares, 2021
Figure 136 F. Hoffmann-La Roche Ltd.: Operating Profit, 2016-2021 (US$ million, AGR%)
Figure 137 F. Hoffmann-La Roche Ltd.: R&D, 2016-2021 (US$ million, AGR%)
Figure 138 Hologic Inc.: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 139 Hologic Inc.: Regional Market Shares, 2021
Figure 140 Hologic Inc.: Gross Profit, 2016-2021 (US$ million, AGR%)
Figure 141 Hologic Inc.: R&D, 2016-2021 (US$ million, AGR%)
Figure 142 Qiagen N.V.: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 143 Qiagen N.V.: Regional Market Shares, 2021
Figure 144 Qiagen N.V.: Gross Profit, 2016-2021 (US$ million, AGR%)
Figure 145 Qiagen N.V.: R&D, 2016-2021 (US$ million, AGR%)
Figure 146 Becton, Dickinson and Company: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 147 Becton, Dickinson and Company: Regional Market Shares, 2021
Figure 148 Becton, Dickinson and Company: Gross Profit, 2016-2021 (US$ million, AGR%)
Figure 149 Becton, Dickinson and Company: R&D, 2016-2019 (US$ million, AGR%)
Figure 150 Siemens Medical Solutions Inc.: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 151 Siemens Medical Solutions Inc.: Gross Profit, 2016-2021 (US$ million, AGR%)
Figure 152 Siemens Medical Solutions Inc.: R&D, 2016-2021 (US$ million, AGR%)
Figure 153 Danaher Corp.: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 154 Danaher Corp.: Regional Market Shares, 2021
Figure 155 Danaher Corp.: Gross Profit, 2016-2021 (US$ million, AGR%)
Figure 156 Agilent Technologies Inc.: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 157 Agilent Technologies Inc.: Regional Market Shares, 2021
Figure 158 Agilent Technologies Inc.: Gross Profit, 2016-2021 (US$ million, AGR%)
Figure 159 Agilent Technologies Inc.: R&D, 2016-2021 (US$ million, AGR%)
Figure 160 Exact Sciences Corp.: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 161 Exact Sciences Corp.: Gross Profit, 2016-2021 (US$ million, AGR%)
Figure 162 Exact Sciences Corp.: R&D, 2016-2021 (US$ million, AGR%)
Figure 163 PerkinElmer, Inc.: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 164 PerkinElmer, Inc.: Regional Market Shares, 2020
Figure 165 PerkinElmer, Inc.: Gross Profit, 2016-2021 (US$ million, AGR%)
Figure 166 PerkinElmer, Inc.: R&D, 2016-2021 (US$ million, AGR%)
Figure 167 bioMérieux SA: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 168 bioMérieux SA: Regional Market Shares, 2019
Figure 169 bioMérieux SA: Gross Profit, 2016-2019 (US$ million, AGR%)
Figure 170 bioMérieux SA: R&D, 2016-2019 (US$ million, AGR%)
Figure 171 Thermo Fisher Scientific: Net Revenue, 2016-2021 (US$ million, AGR%)
Figure 172 Thermo Fisher Scientific: Regional Market Shares, 2021
Figure 173 Thermo Fisher Scientific: Gross Profit, 2016-2021 (US$ million, AGR%)
Figure 174 Thermo Fisher Scientific: R&D, 2016-2021 (US$ million, AGR%)

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（薬学的薬物）の最新刊レポート

皮膚科治療薬市場レポート：2024-2034

Visiongain社の医薬・化学品分野での最新刊レポート

本レポートと同じKEY WORD（MDx）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

Visiongain社はどのような調査会社ですか?

英国の調査会社ヴィジョンゲイン社（Visiongain）は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。